Trends in incidence of skin basal cell carcinoma. Additional evidence from a UK primary care database study

International Journal of Cancer

Volumn 121, Issue 9, 2007, Pages 2105-2108

  Bath Hextall, Fiona ^a   Leonardi Bee, Jo ^a   Smith, Chris ^a   Meal, Andy ^a   Hubbard, Richard ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Incidence; Skin basal cell carcinoma; Trend by age; UK

Indexed keywords

ARTICLE; BASAL CELL CARCINOMA; CANCER INCIDENCE; CANCER RISK; HUMAN; LEISURE; PRIORITY JOURNAL; RADIATION EXPOSURE; SKIN CARCINOMA; ULTRAVIOLET RADIATION; UNITED KINGDOM;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; DATABASES, FACTUAL; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; SEX CHARACTERISTICS; SKIN NEOPLASMS; TIME FACTORS;

EID: 34648834223     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22952     Document Type: Article

References (34)

1. Staples M, Marks R, Giles G. Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect? Int J Cancer 1998;78:144-8.
2. Karagas M, Greenberg E, Spenser S, Stukel T, Mott L. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. New Hampshire Skin Cancer Study Group. Int J Cancer 1999;81:555-9.
3. Chuang T, Popescu N, Su W, Chute G. Basal cell carcinoma. A population-based incidence study in Rochester, Minnesota. J Am Acad Dermatol 1990;22:413-17.
4. Harris R, Griffith K, Moon T. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona. J Am Acad Dermatol 2001;45:528-36.
5. Miller D, Weinstock M. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994;30:774-8.
6. Telfer N, Colver G, Bowers P. Guidelines for the management of basal cell carcinoma. Br J Dermatol 1999;141:415-23.
7. Preston D, Stern R. Nonmelanoma cancers of the skin. New Engl J Med 1992;327:1649-62.
8. Miller S. Biology of basal cell carcinoma (part 1). J Am Acad Dermatol 1991;24:1-13.
9. von Domarus H, Stevens P. Metastatic basal cell carcinoma: report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 1984;10:1043-60.
10. Gloster H, Brodland D. The epidemiology of skin cancer. Dermatol Surg 1996;22:217-26.
11. Leffell D, Headington J, Wong D, Swanson N. Aggressive-growth basal cell carcinoma in young adults. Arch Dermatol 1991;127:1663-7.
12. Goodwin R, Roberts D. Skin cancer registration in the United Kingdom. Br J Dermatol 2001;145:17.
13. Holme S, Malinovszky K, Roberts D. Changing trends in non-melanoma skin cancer in South Wales, 1988-1998. Br J Dermatol 2000;143:1224-9.
14. Marks R, Staples M, Giles G. Trends in non-melanocytic skin cancer treated in Australia: the second national survey. Int J Cancer 1993; 53:585-90.
15. Walberg P, Skog E. The increasing incidence of basal cell carcinoma. Br J Dermatol 1994;131:914-15.
16. Green A, Bearmore G, Hart V, Marks L, Stains D. Skin cancer in Queensland population. J Am Acad Dermatol 1988;19:1045-52.
17. Buettner P, Raasch B. Incidence rates of skin cancer in Townsville. Australia. Int J Cancer 1998;78:587-93. Erratum: 2001;93:302-3.
18. Pearce M, Parker L, Cotterill S, Gorden P, Craft A. Skin cancer in children and young adults: 28 years' experience from the Northern Region Young Person's Malignant Disease Register, UK. Melanoma Res 2003;13:421-6.
19. Christenson L, Borrowman T, Vachon C, Tellefson M, Otley C, Weaver A, Roenigk R. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 2005;294: 681-90.
20. de Vries E, van de Poll-Franse L, Louwman W, de Gruijl F, Coebergh J. Predictions of skin cancer incidence in the Netherlands up to 2015. Br J Dermatol 2005;152:481-8.
21. EPIC. http://www.epic-UK.org/
22. Bourke A, Dattani H, Robinson M. Feasibility study and methodology to create a quality-evaluated database of primary care data. Informat Primary Care 2004;12:171-7.
23. Boyle P, Parkin DM. Statistical methods for registries. In: Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG (eds.). Cancer Registration: Principles and Methods. Lyon: IARC, 1991.
24. de Vries E, Louwman M, Bastiaens M, De Gruijl F, Coebergh J. Rapid and continuous increases in incidence rates of basal cell carcinoma in the Southeast Netherlands since 1973. J Inves Dermatol 2004;123:634-8.
25. Hannuksela-Svahn A, Pukkala E, Karvonen J. Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. Arch Dermatol 1999;135:781-6.
26. Levi F, Franceschi STV, Randimbison L, La Vecchia C. Trends in skin cancer in the Canton of Vaud, 1976-92. Br J Cancer 1995;72: 1047-53.
27. Katalinic A, Kunze U, Schafer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein. Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 2003;149:1200-6.
28. Arranz F, Rubio J, Salvador MMV, Sordos VdV. Descriptive epidemiology of basal cell carcinoma and cutaneous squamous cell carcinoma in Soria (north-eastern Spain) 1998-2000: a hospital survey. JEADV 2004;18:137-41.
29. Levi F, Randimbison L, Maspoli M, Van-Cong T, la Vecchia C. High incidence of second basal cell skin cancers. Int J Cancer 2006;119: 1505-7.
30. Cox N. Basal cell carcinoma in young adults. Br J Dermatol 1992;127:26-9.
31. National Cancer Control Initiative. The 2002 national non-melanoma skin cancer survey. A report by the NCCI Non-melanoma Skin Cancer Working Group. Melbourne: NCCI, 2003.
32. Corona R, Dogliotti E, D'Errico M. Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch Dermatol 2001;137:1162-8.
33. Grossman D, Leffell D. The molecular basis of nonmelanoma skin cancer: new understanding. Arch Dermatol 1997;133:1263-70.
34. Gallagher R, Bajdik C, Fincham S. Chemical exposures, medical history, and risk of squamous and basal cell carcinoma of the skin. Cancer Epidemiol Biomarkers Prev 1996;5:419-24.